Rhode Island Hospital, Dermatopharmacology Division — Providence, Rhode Island

Rhode Island Hospital, Dermatopharmacology Division is a clinical research site located in Providence, Rhode Island, United States 02903.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Rhode Island Hospital, Dermatopharmacology Division has participated in 1 clinical trials.

Therapeutic areas: Actinic Keratoses.

Sponsors: Actavis Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rhode Island Hospital, Dermatopharmacology Division?

Rhode Island Hospital, Dermatopharmacology Division has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rhode Island Hospital, Dermatopharmacology Division conducted?

Rhode Island Hospital, Dermatopharmacology Division has 1 clinical trials on record. Their work covers Actinic Keratoses.

Is Rhode Island Hospital, Dermatopharmacology Division accredited by Crixeo Health?

Rhode Island Hospital, Dermatopharmacology Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rhode Island Hospital, Dermatopharmacology Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.